1. Brijesh, M, Saurav, P. Comparative study of significance of serum cystatin-C, serum creatinine and microalbuminuria estimation in patients of early diabetic nephropathy. J Diabetes Metab 2015; 6: 2.
Google Scholar2. Shaw, JE, Sicree, RA, Zimmet, PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4–14.
Google Scholar | Crossref | Medline | ISI3. Balaji, R, Duraisamy, R, Kumar, MP. Complications of diabetes mellitus: A review. Drug Invent Today 2019; 15: 12.
Google Scholar4. Beckman, JA, Creager, MA. Vascular complications of diabetes. Circ Res 2016; 118: 1771–1785.
Google Scholar | Crossref | Medline5. Long, AN, Dagogo-Jack, S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens 2011; 13: 244–251.
Google Scholar | Crossref | ISI6. Maggiore, U, Budde, K, Heemann, U, et al. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group. Nephrol Dial Transplant 2017; 32: 216–223.
Google Scholar | Crossref | Medline7. Alicic, RZ, Rooney, MT, Tuttle, KR. Diabetic kidney disease. Clin J Am Soc Nephrol 2017; 12: 2032–2045.
Google Scholar | Crossref | Medline8. Selby, NM, Taal, MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab 2020; 22: 3–15.
Google Scholar | Crossref | Medline9. Sternlicht, H, Bakris, GL. Management of hypertension in diabetic nephropathy: how low should we go?. Blood Purif 2016; 41: 139–143.
Google Scholar | Crossref | Medline10. Liu, R, Li, G, Cui, X-F, et al. Methodological evaluation and comparison of five urinary albumin measurements. J Clin Lab Anal 2011; 25: 324–329.
Google Scholar | Crossref | Medline11. Brenner, BM, Hostetter, TH, Humes, HD. Molecular basis of proteinuria of glomerular origin. New Engl J Med 1978; 298: 826–833.
Google Scholar | Crossref | Medline | ISI12. Jim, B, Santos, J, Spath, F, et al. Biomarkers of diabetic nephropathy, the present and the future. Curr Diabetes Rev 2012; 8: 317–328.
Google Scholar | Crossref | Medline13. Bonventre, JV . Current Biomarkers in Kidney Disease: Dawning of a New Era. ASN Kidney News, 2014, p. 7–8.
Google Scholar14. Thornton Snider, J, Sullivan, J, van Eijndhoven, E, et al. Lifetime benefits of early detection and treatment of diabetic kidney disease. PloS One 2019; 14: e0217487.
Google Scholar | Crossref | Medline15. Kim, SS, Song, SH, Kim, IJ, et al. Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy. Diabetes Care 2013; 36: 656–661.
Google Scholar | Crossref | Medline | ISI16. Amer, AH, Haridas, N. Early Diagnostic Markers in Diabetic Nephropathy Patients. J Clin Diagn Res 2018; 12.
Google Scholar17. Gupta, K, Nayyar, SB, Sachdeva, J, et al. Cystatin C in the early diagnosis of diabetic nephropathy and its correlation with albuminuria. Int J Adv Med 2017; 4: 56–59.
Google Scholar | Crossref18. Li, W, Wang, J, Ge, L, et al. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy. Clin Exp Hypertens 2017; 39: 382–387.
Google Scholar | Crossref | Medline19. Takir, M, Unal, AD, Kostek, O, et al. Cystatin-C and TGF-β levels in patients with diabetic nephropathy. Nefrología 2016; 36: 653–659.
Google Scholar | Crossref | Medline20. Papadopoulou-Marketou, N, Skevaki, C, Kosteria, I, et al. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up. Hormones (Athens, Greece) 2015; 14: 232–240.
Google Scholar | Medline21. Shaker, O, El-Shehaby, A, El-Khatib, M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 2010; 61: 731–736.
Google Scholar | SAGE Journals | ISI22. Al-Refai, AA, Tayel, SI, Ragheb, A, et al. Urinary neutrophil gelatinase associated lipocalin as a marker of tubular damage in type 2 diabetic patients with and without albuminuria. Open J Nephrol 2014; 2014.
Google Scholar23. Motawi, TK, Shehata, NI, ElNokeety, MM, El-Emady, YF. Potential serum biomarkers for early detection of diabetic nephropathy. Diabetes Res Clin Pract 2018; 136: 150–158.
Google Scholar | Crossref | Medline24. DyabAllawi, AA, Nada, SZ, Turki, KM. Neutrophil gelatinase associated lipocalin (NGAL) in early detection of nephropathy in type 2 diabetic Iraqi patients. J Fac Med Baghdad 2017; 59: 74–78.
Google Scholar | Crossref25. Veiga, G, Alves, B, Perez, M, et al. NGAL and SMAD1 gene expression in the early detection of diabetic nephropathy by liquid biopsy. J Clin Pathol 2020; 73: 713–721.
Google Scholar | Crossref | Medline26. van Deursen, VM, Damman, K, Voors, AA, et al. Renal tubular damage. Comorbidity Heart Failure 2013; 52.
Google Scholar27. Singer, E, Markó, L, Paragas, N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol 2013; 207: 663–672.
Google Scholar | Crossref | Medline28. Bolignano, D., Lacquaniti, A, Coppolino, G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337–344.
Google Scholar | Crossref | Medline | ISI29. Nauta, FL, Boertien, WE, Bakker, SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011; 34: 975–81981.
Google Scholar | Crossref | Medline | ISI30. Sharifi, AM, Zare, B, Keshavarz, M, et al. Urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the early detection of diabetic nephropathy. Int J Diabetes Developing Countries 2015; 35: 369–374.
Google Scholar | Crossref31. Aguilar, B, Rojas, JC, Collados, MAT. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 2004; 18: 75–87.
Google Scholar | Crossref | Medline | ISI32. Ye, B, Zhu, X, Zeng, Z, et al. Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients. Pteridines 2021; 32: 11–16.
Google Scholar | Crossref33. Reidy, K, Kang, HM, Hostetter, T, et al. Molecular mechanisms of diabetic kidney disease. J Clin Invest 2014; 124: 2333–2340.
Google Scholar | Crossref | Medline34. Zhang, H, Yang, H, Zhang, C, et al. Investigation of microRNA expression in human serum during the aging process. The Journals Gerontol Ser A 2015; 70: 102–109.
Google Scholar | Crossref | Medline35. Stephenson, RO, Yamanaka, Y, Rossant, J. Disorganized epithelial polarity and excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. Development 2010; 137: 3383–3391.
Google Scholar | Crossref | Medline36. Lamouille, S, Xu, J, Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cel Biol 2014; 15: 178–196.
Google Scholar | Crossref | Medline | ISI37. El-Dawla, NMQ, Sallam, A-AM, El-Hefnawy, MH, et al. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition. Clin Exp Nephrol 2019; 23: 1050–1057.
Google Scholar | Crossref | Medline38. Chijimatsu, R, Kunugiza, Y, Taniyama, Y, et al. Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskeletal Disorders 2015; 16: 1–2.
Google Scholar | Crossref | Medline39. Satirapoj, B, Wang, Y, Chamberlin, MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant 2012; 27: 2702–2711.
Google Scholar | Crossref | Medline | ISI40. Hafizi, S, Dahlbäck, B. Gas6 and protein S. FEBS J 2006; 273: 5231–5244.
Google Scholar | Crossref | Medline | ISI41. Nagai, K, Arai, H, Yanagita, M, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003; 278: 18229–18234.
Google Scholar | Crossref | Medline42. Moustakas, A, Heldin, C-H. Mechanisms of TGFβ-induced epithelial-mesenchymal transition. J Clin Med 2016; 5: 63.
Google Scholar | Crossref43. Abe, H, Matsubara, T, Arai, H, Doi, T. Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histology and Histopathology 2011; 26: 531–541.
Google Scholar | Medline44. Chioran, A, Duncan, S, Catalano, A, et al. Collagen IV trafficking: the inside-out and beyond story. Dev Biol 2017; 431: 124–133.
Google Scholar | Crossref | Medline45. Wang, J-Y, Gao, Y-B, Zhang, N, et al. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol 2014; 392: 163–172.
Google Scholar | Crossref | Medline46. Mohammadi‐Karakani, A, Asgharzadeh‐Haghighi, S, Ghazi‐Khansari, M, et al. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 2007; 21: 413–417.
Google Scholar | Crossref | Medline | ISI47. Lardizabal, JA, Deedwania, PC. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiology Reports 2010; 12: 464–471.
Google Scholar | Crossref | Medline48. Chang, AS, Hathaway, CK, Smithies, O, et al. Transforming growth factor-β1 and diabetic nephropathy. Am Journal Physiology. Ren Physiology 2016; 310: F689–F696.
Google Scholar | Crossref | Medline49. Ibrahim, S, Rashed, L. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus. Saudi Medical Journal 2007; 28: 519–523.
Google Scholar | Medline50. Sharma, K, Ziyadeh, FN, Alzahabi, B, et al. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 1997; 46: 854–859.
Google Scholar | Crossref | Medline | ISI51. Kersten, S . Physiological regulation of lipoprotein lipase. Biochim Biophys Acta (Bba) - Mol Cel Biol Lipids 2014; 1841: 919–933.
Google Scholar | Crossref | Medline52. Rajwani, A, Ezzat, V, Smith, J, et al. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes 2012; 61: 915–924.
Google Scholar | Crossref | Medline53. Vasylyeva, TL, Ferry, RJ. Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy. Diabetes Res Clin Pract 2007; 76